This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Australian Broadcasting Corporation (2003) White mischief Transcript available atwww.abc.net.au/4corners/content/2003/transcripts/s820943.htm.
Banks WA, Kastin AJ (1987). Saturable transport of peptides across the blood-brain barrier. Life Sci 41 (11), 1319–1338.
Beales PE, Elliott RB, Flohe S, Kolb H, Hill JP, Pozzilli P et al. (2002). A multi-centre, blinded international trial of the effect of A1 and A2 beta-casein variants on diabetes incidence in two rodent models of spontaneous type 1 diabetes. Diabetologia 45 (9), 1240–1246. [e-pub 2002 Jul 19].
Birgisdottir BE, Hill JP, Harris DP, Thorsdotter A (2002). Variation in consumption of cow milk proteins and lower incidence of Type 1 diabetes in Iceland vs the other 4 Nordic countries. Diab Nutr Metab 15, 240–245.
Cade R, Privette M, Fregly M, Rowland N, Sun Z, Zele V et al. (2000). Autism and Schizophrenia: Intestinal Disorders. Nutritional Neuroscience March 2000.
Chabance B, Marteau P, Rambaud JC, Migliore (1998). Casein peptide release and passage to the blood in humans during digestion of milk or yogurt. Biochimie 80 (2), 155–165.
Channel 7 (2003). Today Tonight, Australia. Wonder Milk. Helen Wellings, July 2003. Transcript available athttp://seven.com.au/todaytonight/results/A2%20Milk/0.
Cone DH (2002). Secret memo reveals Fonterra alarm. National Business Review p14: Nov 1.
FitzGerald RJ, Meisel H (2000). Milk protein-derived peptide inhibitors of angiotensin-I-converting enzyme. Br J Nutr 84 (Suppl 1), S33–S37.
Herrera-Marschitz M, Terenius L, Grehn L, Ungerstedt U (1989). Rotational behaviour produced by intranigral injections of bovine and human beta-casomorphins in rats. Psychopharmacology (Berlin) 99 (3), 357–361.
Jinsmaa Y, Yoshikawa M (1999). Enzymatic release of neo-casomorphin and beta casomorphin from bovine beta-casein. Peptides V 20 (8), 957–962.
Knivsberg AM, Reichelt KL, Hoien T, Nodland M (2002). A randomised, controlled study of dietary intervention in autistic syndromes. Nutr Neurosci 5 (4), 251–261.
Meisel H, FitzGerald RJ (2000). Opioid peptides encrypted in intact milk protein sequences. Br J Nutr 83 (Suppl 1), S27–S31.
Nyberg F, Lieberman H, Lindstrom LH, Lyrenas S, Koch G, Terenius L (1989). Immunoreactive beta-casomorphin-8 in cerebrospinal fluid from pregnant and lactating women: correlation with plasma levels. J Clin Endocrinol Metab 68 (2), 283–289.
Padberg S, Schumm-Draeger PM, Petzoldt R, Becker F, Federlin K (1999). Article in German.) [The significance of A1 and A2 antibodies against beta-casein in type-1 diabetes mellitus]. Dtsch Med Wochenschr 124 (50), 1518–1521.
Panksepp J, Normansell L, Siviy S, Rossi 3rd J, Zolovick AJ (1984). Casomorphins reduce separation distress in chicks. Peptides 5 (4), 829–831.
Pozzilli P (1999). β-casein in cow's milk: A major anitgentic determinant for type 1 diabetes? J Endocrinol Invest 22, 562–567.
Scott FW (1996). Food induced type 1 diabetes in the BB rat. Diabetes Metab Rev 12, 341–359.
Shah N (2000). Effects of Milk-derived bioactives: an overview. Br J Nutr 84 (Suppl. 1), S3–310.
Singh M, Rosen CL, Chang KJ, Haddad GG (1989). Plasma beta-casomorphin-7 immunoreactive peptide increases after milk intake in newborn but not in adult dogs. Pediatr Res 26 (1), 34–38.
Siow RC, Richards JP, Pedley KC, Leake DS, Mann GE (1999). Vitamin C protects human vascular smooth muscle cells against apoptosis induced by moderately oxidized LDL containing high levels of lipid hydroperoxides. Arterioscler Thromb Vasc Biol 19 (10), 2387–2394.
Steinerova A, Racek J, Rajdl D, Stožicky F, Rokyta Z, Trefil L et al. (2004) Letter to the Editor V 173: 1, 147–148.
Steinerova A, Racek J, Stozicky F, Tatzber F (1999). Autoantibodies against oxidised LDL in the first phase of life. Clin Chem Lab Med 37 (9), 213–217.
Steinerova A, Racek J, Stozicky F, Tatzber F (2001). Autoantibodies against oxidised LDL in infants. Clin Chem 47 (6), 1137–1138.
Sun Z, Zhang Z, Ang X, Cade R, Elmir Z, Fegly M (2003). Relation of beta-casomorphin to Apnea in Sudden Infant Death Syndrome. Peptides 24 (6), 937–943.
Svedberg J, de Haas J, Leimenstoll G, Paul F, Teschemacher H (1985). Demonstration of β-casomorphin immunoreactive materials in In vitro digests of bovine milk and in small intestine contents after bovine milk ingestion in adult humans. Peptides V 6, 825–830.
Tailford KA, Berry CL, Thomas AC, Campbell JH (2003). A casein variant in cow's milk is atherogenic. Atherosclerosis 170 (1), 13–19.
Torreilles J, Guerin MC (1995). Casein-derived peptides promote peroxidase-dependent oxidation of human blood low-density lipoproteins. CR Seances Soc Biol Fil 189 (5), 933–942.
Umbach M, Teschemacher H, Praetorius K, Hirschhauser R, Bostedt H (1985). Demonstration of a beta-casomorphin immunoreactive material in the plasma of newborn calves after milk intake. Regul Pept 12 (3), 223–230.
Wasmuth HE, Rosenbauer J, Elliott RB, McLachlan C, Erhardt G, Giani G et al. (1999). β-casein A1 consumption and incidence of Type 1 Diabetes in Germany. Kongress der Europäischen Diabetesgesellschaft vom 28, 30.09.1999 in Brüssel/Belgien.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Allison, A., Clarke, A. Further research for consideration in ‘the A2 milk case’. Eur J Clin Nutr 60, 921–924 (2006). https://doi.org/10.1038/sj.ejcn.1602276
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.ejcn.1602276
This article is cited by
-
A2 milk consumption and its health benefits: an update
Food Science and Biotechnology (2024)
-
Demographic pattern of A1/A2 beta casein variants indicates conservation of A2 type haplotype across native cattle breeds (Bos indicus) of India
3 Biotech (2022)